表 1.
CAMSAP2的表达量和胃癌恶性进展参数正相关
CAMSAP2 expression level is positively correlated with progression of gastric cancer
| Factors | n | CAMSAP2 expression (n, %) | χ2 | P | ||
| Low (n=53) | High (n=53) | |||||
| Gender | Male | 45 | 25 (55.6%) | 20 (44.4%) | 0.965 | 0.326 |
| Female | 61 | 28 (45.9%) | 33 (54.1%) | |||
| Age (year) | < 60 | 36 | 19 (52.8%) | 17 (47.2%) | 0.168 | 0.682 |
| ≥60 | 70 | 34 (48.6%) | 36 (51.4%) | |||
| CEA (μg/L) | < 5 | 49 | 41 (83.7%) | 8 (16.3%) | 41.330 | < 0.001 |
| ≥5 | 57 | 12 (21.1%) | 45 (78.9%) | |||
| CA19-9 (kU/L) | < 37 | 57 | 39 (68.4%) | 18 (31.6%) | 16.737 | < 0.001 |
| ≥37 | 49 | 14 (28.6%) | 35 (71.4%) | |||
| Tumor size (cm) | < 5 | 41 | 21 (51.2%) | 20 (48.8%) | 0.040 | 0.842 |
| ≥5 | 65 | 32 (49.2%) | 33 (50.8%) | |||
| Cancer cell type | Adenocarcinoma | 42 | 25 (59.5%) | 17 (40.5%) | 2.524 | 0.112 |
| Other | 64 | 28 (43.8%) | 36 (56.3%) | |||
| T stage | 1-2 | 50 | 43 (86%) | 7 (14%) | 49.063 | < 0.001 |
| 3-4 | 56 | 10 (17.9%) | 46 (82.1%) | |||
| N stage | 0-1 | 49 | 34 (69.4%) | 15 (30.6%) | 13.701 | < 0.001 |
| 2-3 | 57 | 19 (33.3%) | 38 (66.7%) | |||